ZOLETIL 50, ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
ZOLETIL 50, ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Tiletamine hydrochloride
- Zolazepam hydrochloride
Product identification
Medicine name:
ZOLETIL 50, ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Tiletamine hydrochloride
- Zolazepam hydrochloride
Target species:
-
Cat
-
Dog
Route of administration:
-
Intramuscular and intravenous use
Product details
Active substance and strength:
-
Tiletamine hydrochloride125.00/milligram(s)1.00Vial
-
Zolazepam hydrochloride125.00/milligram(s)1.00Vial
Pharmaceutical form:
-
Powder and solvent for solution for injection
Withdrawal period by route of administration:
-
Intramuscular and intravenous use
- Cat
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 39643/19/26-11-2019/K-0067101
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
